Genomics and the classification of mental illness: Focus on broader categories

Rudolf Uher

doi:10.1186/gm501

Genomics and the classification of mental illness: Focus on broader categories

Rudolf Uher

Institutional Research Division

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Article number	97
Journal	Genome Medicine
Volume	5
Issue number	10
DOIs	https://doi.org/10.1186/gm501
Publication status	Published - Oct 25 2013

ASJC Scopus Subject Areas

Molecular Medicine
Molecular Biology
Genetics
Genetics(clinical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/gm501

Cite this

@article{7ae3c1efb8894f30ab22cda011ae14e6,

title = "Genomics and the classification of mental illness: Focus on broader categories",

author = "Rudolf Uher",

note = "Funding Information: RU is supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) and grants from the Canadian Institutes of Health Research, the Nova Scotia Health Research Foundation and the European Commission Innovative Medicine Initiative Joint Undertaking (#115008). Funding Information: RU consults for the World Health Organization. He has co-chaired a steering board of a research project, unrelated to the present article, initiated and funded by Bristol Myers Squibb. RU has received no personal income from pharmaceutical or biotech industry and holds no equity in companies active in medicine, pharmaceuticals or biotechnology.",

year = "2013",

month = oct,

day = "25",

doi = "10.1186/gm501",

language = "English",

volume = "5",

journal = "Genome Medicine",

issn = "1756-994X",

publisher = "BioMed Central",

number = "10",

}

TY - JOUR

T1 - Genomics and the classification of mental illness

T2 - Focus on broader categories

AU - Uher, Rudolf

N1 - Funding Information: RU is supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) and grants from the Canadian Institutes of Health Research, the Nova Scotia Health Research Foundation and the European Commission Innovative Medicine Initiative Joint Undertaking (#115008). Funding Information: RU consults for the World Health Organization. He has co-chaired a steering board of a research project, unrelated to the present article, initiated and funded by Bristol Myers Squibb. RU has received no personal income from pharmaceutical or biotech industry and holds no equity in companies active in medicine, pharmaceuticals or biotechnology.

PY - 2013/10/25

Y1 - 2013/10/25

UR - http://www.scopus.com/inward/record.url?scp=84887954461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887954461&partnerID=8YFLogxK

U2 - 10.1186/gm501

DO - 10.1186/gm501

M3 - Article

AN - SCOPUS:84887954461

SN - 1756-994X

VL - 5

JO - Genome Medicine

JF - Genome Medicine

IS - 10

M1 - 97

ER -

Genomics and the classification of mental illness: Focus on broader categories

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this